Fast forward into 2026 and with AI summary availability plus me being lazy to read and absorb all the latest update...6 years after the original thread was made....
As of early 2026, the CRISPR/Cas9 technique has moved beyond foundational gene-cutting into an era of high-precision, "on-demand" genome editing, with significant clinical successes in treating genetic diseases and cancer
. Key developments include improved delivery methods, reduced off-target effects, and the introduction of advanced derivatives like base and prime editing.
Now I am more anxious!